Provided by Tiger Fintech (Singapore) Pte. Ltd.

NEUROONE MEDICAL TECH

0.8936
+0.04355.12%
Post-market: 0.8921-0.0015-0.17%18:05 EDT
Volume:514.85K
Turnover:464.67K
Market Cap:44.68M
PE:-5.88
High:0.9380
Open:0.8832
Low:0.8780
Close:0.8501
52wk High:1.39
52wk Low:0.3954
Shares:50.00M
Float Shares:43.60M
Volume Ratio:1.30
T/O Rate:1.18%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1521
EPS(LYR):-0.4603
ROE:-95.39%
ROA:-45.07%
PB:5.46
PE(LYR):-1.94

Loading ...

Mark Christianson, Business Development Director, Reports Disposal of Common Shares in Neuroone Medical Technologies Corp

Reuters
·
2 hours ago

NeuroOne Medical Tech Initiated at Buy by Maxim Group

Dow Jones
·
Yesterday

Maxim Initiates NeuroOne Medical Technologies at Buy With $3 Price Target

MT Newswires Live
·
Yesterday

NeuroOne® to Participate in Sidoti Small-Cap Conference on September 17th and 18th, 2025

GlobeNewswire
·
Yesterday

NeuroOne Medical Technologies Gets FDA Clearance for OneRF Trigeminal Nerve Ablation System

MT Newswires Live
·
Aug 18

Neuroone® Receives FDA 510(K) Clearance for Onerf® Trigeminal Nerve Ablation System to Treat Facial Pain

THOMSON REUTERS
·
Aug 18

BRIEF-NeuroOne Medical Technologies Files Prospectus For $6.75 Million Share Sale

Reuters
·
Aug 16

Neuroone Medical Technologies Corp - Files Prospectus for $6.75 Mln Share Sale - SEC Filing

THOMSON REUTERS
·
Aug 16

NeuroOne Medical Technologies Corporation Initiates ATM Program for Sale of Up to $6.75 Million in Shares Through JonesTrading

Reuters
·
Aug 16

NeuroOne Q3 FY2025 Earnings Call Summary and Q&A Highlights: Revenue Growth, Margin Expansion, and Pipeline Progress

Earnings Call
·
Aug 14

NeuroOne Medical Tech Q3 EPS $(0.03) Beats $(0.05) Estimate, Sales $1.70M Miss $1.82M Estimate

Benzinga
·
Aug 14

BRIEF-NeuroOne Medical Technologies Q3 Operating Expenses USD 2.8 Million

Reuters
·
Aug 14

Neuroone Medical Technologies Corp - Q3 Product Revenue $1.7 Mln

THOMSON REUTERS
·
Aug 14

Neuroone Medical Technologies Q3 Net Income USD -1.5 Million

THOMSON REUTERS
·
Aug 14

Neuroone Medical Technologies Corp - Continues to Expect Product Revenue for FY 2025 to Range Between $8.0 Million - $10.0 Million

THOMSON REUTERS
·
Aug 14

Neuroone Medical Technologies Q3 EPS USD -0.03

THOMSON REUTERS
·
Aug 14

NeuroOne® Reports Third Quarter Fiscal Year 2025 Financial Results; Revenue Increases 105% YoY and Gross Margin Expands to 53.9%

GlobeNewswire
·
Aug 14

NeuroOne Medical Technologies Corp expected to post a loss of 5 cents a share - Earnings Preview

Reuters
·
Aug 12

NeuroOne® to Report Third Quarter Fiscal Year 2025 Financial Results on Thursday, August 14 at 8:30 a.m. Eastern Time

GlobeNewswire
·
Jul 31

Neuroone® Receives Notice of Allowance for Key Patent From U.S. Patent & Trademark Office

THOMSON REUTERS
·
Jul 23